Trademark Details For CVS PHARMACY (Serial Number 86879078)

  •  Home
  •  Print
CVS PHARMACY
3
10
7
0
Basic Information
Serial Number  United States - USPTO 86879078
Registration Number 5157590
Mark
CVS PHARMACY
Filing Date Jan-19-2016
Status
Registered  
SECTION 8 & .. (702)
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Attorney Name
TTAB
0


  • CVS PHARMACY, INC

  • Description Of Mark:
  • Color(s) Claimed:
  • Disclaimer:

035Advertising and business

U.S Class(es): 100, 101, 102

Class Status: Active

First Use: May-22-2016

First Use in Commerce: May-22-2016


02.11.01



Correspondences

NameErich G. Rhynhart
AddressCVS PHARMACY, INC. MAIL CODE 1160 ONE CVS DRIVE WOONSOCKET RI 02895

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jan-22-2016NEW APPLICATION ENTERED   NWAPI
Jan-22-2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Jan-23-2016NOTICE OF DESIGN SEARCH CODE E-MAILED   MDSCE
Mar-09-2016ASSIGNED TO EXAMINER   DOCKD
Mar-16-2016APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Apr-20-2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
May-10-2016PUBLISHED FOR OPPOSITION   PUBOA
May-10-2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Jul-05-2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Dec-20-2016TEAS STATEMENT OF USE RECEIVED   EISUI
Jan-13-2017CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Dec-20-2016USE AMENDMENT FILED   IUAFS
Jan-17-2017STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Feb-01-2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED   CNPRP
Feb-02-2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED   SUNAE
Mar-07-2017REGISTERED-PRINCIPAL REGISTER   R.PRA
Mar-07-2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Feb-21-2023TEAS SECTION 8 & 15 RECEIVED   E815I
Aug-18-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Aug-23-2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Aug-23-2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED   NA85E